Chemotherapy Induced Acral Erythema Treatment Market

Chemotherapy Induced Acral Erythema Treatment Market

Chemotherapy Induced Acral Erythema (Hand-Foot Syndrome) Treatment Market: Global Industry Analysis and Forecast 2016 - 2022

ID: PMRREP10097

Upcoming

Author : Abhijeet Surwase

Introduction

Acral erythema, also called as hand-foot syndrome or palmar-plantar erythrodysesthesia, is characterized by swelling, redness, paraesthesia (numbness) and desquamation (skin peeling) of palms, soles and rarely on knees and elbow. Acryl erythema is an adverse drug reaction which typically appear after several months of treatment with chemotherapeutic agents, gemcitabine and fluorouracil being the most common drugs causing reaction.

Chemotherapy induced acryl erythema is a dose dependent condition, regression of which can be achieved by discontinuation of chemotherapy or by dose reduction. Treatment for chemotherapy induced acryl erythema includes symptomatic treatment with analgesics and antihistaminic drugs to reduce pain and edema.

Surge in usage of chemotherapeutic agents due to increasing incidence of cancers is the major growth driver of global chemotherapy induced acral erythema treatment market.

According to WHO cancer factsheet 2015, the worldwide incidence of cancers is expected to increase by 70% in next 2 decades which perhaps influence the growth of global chemotherapy induced acral erythema treatment market over the forecast period from 2016–2026. Moreover, lifestyle up-gradation, increasing number of smokers are some secondary considerations accountable for rise in global chemotherapy induced acral erythema treatment market.

The report covers exhaustive analysis on:

  • Chemotherapy Induced Acral Erythema (Hand-Foot Syndrome) Treatment Market Segments
  • Chemotherapy Induced Acral Erythema (Hand-Foot Syndrome) Treatment Market Dynamics
  • Historical Actual Market Size, 2013 - 2015
  • Chemotherapy Induced Acral Erythema (Hand-Foot Syndrome) Treatment Market Size & Forecast 2016 to 2022
  • Chemotherapy Induced Acral Erythema (Hand-Foot Syndrome) Treatment Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Chemotherapy Induced Acral Erythema (Hand-Foot Syndrome) Treatment Drivers and Restraints

Regional analysis includes

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Report Highlights:

  • Shifting Industry dynamics
  • In-depth market segmentation
  • Historical, current and projected industry size Recent industry trends
  • Key Competition landscape
  • Strategies of key players and product offerings
  • Potential and niche segments/regions exhibiting promising growth
  • A neutral perspective towards market performance
UK

Corporate Office

Persistence Research & Consultancy Services Limited

Company Number : 15310893

Second Floor, 150 Fleet Street,London, EC4A 2DQ.

+44 203-837-5656
India

Global Research centre

Persistence Market Research Private Limited

CIN : U74900PN2014PTC153163

IT Unit No. 504, 5th Floor, IconTower, Baner, Pune - 411045.

+91 906 779 3500

Copyright © 2026 Persistence Market Research. All Rights Reserved

Connect With Us -